Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Primary Objective: To evaluate the efficacy of ultrasound-guided nsPFA™ in the treatment of patients with T1N0M0 PTC as measured by the thyroid nodule volume changes including volume reduction rate (VRR), technique efficacy (TE) and nodule regrowth (NR) during post procedure follow-up. Secondary Objectives: To assess the clinical safety and complications of the CellFX Percutaneous Electrode (PE) System To evaluate the ultrasound features of thyroid nodules over time following ultrasound-guided nsPFA. To determine the health-related quality of life changes over time induced by ultrasound-guided nsPFA.